Historically, the chemicals industry has generated strong returns for shareholders and society, transforming everyday lives and creating high-quality jobs. But the industry’s position as a driver of economic growth is under threat. Between December 2021 and November 2025, total shareholder returns (TSR) in the global chemicals industry declined by 7 percent CAGR, versus 9 percent TSR growth across the global economy.1
This erosion of value is not just cyclical noise; it is a sign of an industry under pressure. Globally, especially in Europe, the chemicals industry has faced an unprecedented combination of structural demand shifts, cost disadvantages, and regulatory changes in recent years. While the top 15 chemicals companies grew their revenues by 15 percent over the past five years, capital expenditure remained flat. Overall, capital productivity has decreased in Western geographies.
Further complicating these challenges, industry assets are aging, and capital requests are increasing. Cost and schedule performance have worsened, with large projects in particular continuing to overrun. Capital scarcity is now a prolonged constraint for the sector.
Within this context, leaders in chemicals have started looking beyond classic operational levers—procurement, manufacturing, supply chain, or commercial—to create value and strategic distance from other companies. Capital expenditure is now, rightly, coming under far greater scrutiny.
Capital expenditure has remained a largely untapped source of value, with its complexity and technical nature acting as barriers. Comparing and prioritizing hundreds, if not thousands, of capital projects in terms of their merit is inherently difficult, as is shaping projects to boost ROI and delivering them on cost and to schedule.
The good news is that agentic AI has made business case challenging, value-based metrics, rankings, trade-off discussions, and data-driven project delivery more accessible. Projects were once difficult to compare in large portfolios, but AI enables faster and deeper challenges to assumptions, highlighting trade-offs more clearly and supporting more confident investment decision-making at scale.
A renewed focus on capital excellence could be instrumental in helping chemicals companies reposition the industry as a value-generating engine of growth. Early movers have potential to enjoy superior returns over slower organizations.
A challenging European landscape
Chemicals companies face external challenges that have material impact on their capital decisions. Particularly in Europe, several fundamental forces are at play.
The chemicals industry is experiencing pressure on demand as traditional demand-driving industries, such as automotive, contend with structural changes of their own. For example, the global market share of European OEMs in electric passenger vehicles has dropped 20 percent since 2017.2
Europe also faces persistent cost headwinds, including higher energy prices and labor costs. Asia benefits from lower labor costs, and the Middle East from advantaged feedstock, for example.3 These structural differences fundamentally challenge the economics of European chemicals assets.
Amid such challenges, the investment activity of Western Europe’s chemicals industry remains subdued at a projected 1.0 percent CAGR for 2026 through 2030 (real value). This would continue the low levels of investment seen from 2015 to 2025, when CAGR decreased by 0.6 percent, and stands in stark contrast to the period 1980 to 1990, when CAGR was at more than 3.4 percent.4 With many chemicals companies delivering large growth projects only occasionally in recent years, project delivery capabilities have decreased in many organizations.
Against this backdrop of scarce capital and reduced capabilities, every euro must work harder to deliver value, and every investment and project steering decision matters.5 This is especially true given that the sector’s capital performance is below that of other sectors, such as manufacturing.
The untapped capital expenditure opportunity
In an environment characterized by largely uncontrollable factors such as demand, energy costs, and regulation, capital excellence could be a decisive lever for value creation. According to our research, most companies that excel in capital allocation outperform their peers. Companies that reallocate a large share (49 percent, in our sample) of their capital between business units every year achieve much higher TSR CAGRs than peers that reallocate 30 percent of their capital.6 We frequently see companies that excel in project delivery achieve 15 to 30 percent cost savings, including in operating expenditure, and boost ROIC by 2 to 4 percent, freeing up resources for high-value opportunities.
However, realizing this value is not simple. Selecting and delivering the right projects has become increasingly difficult as uncertainty and complexity rise. Several recurring pitfalls prevent companies from realizing the full value of their capital:
- Top-down guidance. Companies often allocate capital based on historical levels, rather than through top-down guidance underpinned by benchmarks or should-cost analysis, leading to persistent over- or underinvestment.
- Project evaluation. Limited understanding of how much value each project has created is not uncommon. Inconsistent assumptions, incomplete business cases, and a lack of focus on ROI obscure true performance and risk. One chemicals company recently discovered that 10 percent of its projects lacked a sound business case. A further 15 percent had metrics, such as risk score or return on capital employed (ROCE), that misrepresented their merit; these needed updating to support like-for-like comparison. These issues were rooted in inconsistencies across methodologies and assumptions. Such opacity can undermine confidence in investment decisions and contribute to the misallocation of capital.
- Portfolio optimization. In the absence of rigorous, enterprise-wide prioritization mechanisms, capital expenditure allocation can become a negotiation exercise rather than a value-based decision. Projects are often approved based on local influence, perceived urgency, or historical precedent, rather than their relative contribution to value creation. Limited cross-business and cross-site comparisons can prevent trade-offs at the margin, with the result that scarce capital is spread across projects rather than allocated to the highest-impact opportunities.
- Project delivery optimization. Companies often wrestle with setting up projects for success—rightsizing organizations, adhering to appropriate governance, visualizing insightful project data, and selecting fit-for-purpose delivery models and contractors. But if companies do not sufficiently optimize project scope, decision-makers may approve low-added-value options, and if project management practices are suboptimal, productivity may decline. Meanwhile, limited innovation continues to drag down the construction industry, which plays a critical role in the successful delivery of capital expenditure projects in the chemicals industry.7
- People and enablers. Chemicals companies still have significant opportunity to increase their use of digital tools, advanced analytics, and automation to boost productivity and improve decision-making across the capital project’s life cycle. The construction industry, too, has been slower than many others to adopt new technologies, but it now faces a critical imperative to rewire its operating model and build more with fewer resources.8 Demographic shifts, including rising retirement levels, are eroding institutional knowledge and critical project management capabilities. Suitable talent is not always available to replace these skills at the required pace or to support new, technology-enabled ways of working.9 Without targeted investment in people and enablers, companies may find it difficult to achieve capital excellence in practice.
Five focus areas for capital excellence
While the challenges are many, chemicals companies could see significant returns from their efforts to improve capital excellence. One European chemicals company managed to achieve a 20 percent value uplift in its portfolio through end-to-end capital expenditure transformation. Other chemicals companies could create value via a renewed focus on capital excellence that addresses the following five practices associated with high performance.
Portfolio optimization through like-for-like comparison
In our experience, companies achieve the best outcomes over time when they start their annual capital allocation process with informed top-down guidance, including should-spend targets for their sustaining capital expenditures, informed by technical and financial benchmarks as well as specific risks and opportunities.
After that, all project business cases should undergo pressure testing and be evaluated with consistent value-based metrics and assumptions to enable like-for-like comparison. With consistent metrics established, teams can rank projects, configure portfolios, and make trade-offs at the margin, comparing scenarios with aggregated metrics to support decision-making.
Getting portfolio optimization right can have an outsized impact. As one executive at a chemicals company put it, “This holistic and thought-through portfolio optimization process gives me real confidence that we have selected the right projects for our company to invest in.”
Thorough project development based on clear requirements
Ensuring that project development is thorough and sufficiently mature at the final-investment-decision (FID) stage is critical to make sure every euro invested maximizes returns, scope is optimized, and projects do not experience cost and schedule overruns.
Setting up projects for success in terms of organization, governance, contracting strategies, and procurement spans several crucial areas. These include appropriately resourcing projects in terms of skills and staffing levels, completing all required deliverables on time with the right level of quality, developing fit-for-purpose delivery models, promoting collaboration and good practices through terms and conditions, and informing negotiations with should-cost analysis.
It is equally important to clarify the requirements from business, operations, and other stakeholders; distinguish what is mandatory from what is discretionary within those requirements; articulate the minimum technical solution; and frame alternatives as options to be validated on their own merit.
Flawless execution to reduce change orders
The project execution stage demands efficiency across the board, including optimized schedules and contractor productivity. Methods that can help companies pursue efficiency include use of state-of-the-art methods such as generative scheduling, as well as thorough bottom-up planning and performance management so all project constraints are surfaced and resolved ahead of time to support flow on site. Effective front-end loading, contract management, collaboration, and joint problem-solving with contractors to resolve issues rapidly can contribute to productivity and reduce lengthy—and costly—change orders.
Rewired operating system for AI
Rewiring the operating system for an AI era can unlock new levels of performance by reimagining workflows. AI can support engineering development, significantly reduce design time, and improve value generated by rapidly identifying where unnecessary specifications lead to excessive scope or by helping to make contractor terms and conditions more robust. A chemicals company recently leveraged AI to challenge its process and civils design for a key investment project, and by doing so, it was able to reduce costs by 15 percent.
Generative scheduling, including data-driven scheduling using parametric models and advanced analytics, can optimize schedules beyond what project schedulers achieve by using traditional scheduling tools alone. For example, a European chemicals company was able to accelerate its schedule by three months through generative scheduling. With real-time tracking and AI-enabled simulation, schedules can now adapt to the evolving conditions of construction project delivery, with smart analytics transforming project data into predictive insights that support proactive decision-making and accelerated performance.
When applied in isolation, these solutions improve today’s practices; together, they fundamentally rewire entire domains. Capturing the benefits of this reconfiguration will require new capabilities so teams can deliver more value faster and bring appropriate judgment.
Right talent and organization to drive consistent results
Teams that achieve results from their end-to-end capital excellence transformations share common traits and capabilities: ambition, openness, problem-solving, and business acumen. In reconfigured contexts where AI use is expanding, these traits become even more important.
Human support is needed to back up AI in many areas of capital project execution, including forward-looking cost and schedule analyses supported by data and human judgment; AI-orchestrated workflows with human oversight; and autonomous AI agents with human-in-the-loop embedded throughout execution. Human skills will continue to be used in both automatable and nonautomatable work. Therefore, to have skilled talent in place as AI use expands, companies need to provide for upskilling and training, as well as hire the right people.
The global chemicals industry, especially in Europe, is at a critical juncture. The challenges are significant, but so are the opportunities for companies that can act decisively to bring in new capabilities to evaluate and execute their capital projects.
Companies can adopt a disciplined, data-driven approach to capital expenditure by optimizing investments, unlocking savings, and reinvesting in future growth. Mastering capital expenditure may yet drive resilience and sustainable growth in the chemicals industry for years to come.


